KALA

KALA BIO, Inc. - Common Stock (KALA)

About KALA BIO, Inc. - Common Stock (KALA)

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Details

Daily high

$4.10

Daily low

$3.85

Price at open

$4.08

52 Week High

$11.20

52 Week Low

$2.92

Market cap

26.1M

Dividend yield

0.00%

Volume

12,501

Avg. volume

94,917

P/E ratio

-.49

KALA BIO, Inc. - Common Stock News